Clinical trial NCT00789698 - References

Chronic Schizophrenia — Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia

Citation(s)

•   Harvey PD, Siu CO, Hsu J, Cucchiaro J, Maruff P, Loebel A
  Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension. Eur Neuropsychoph
•   Loebel A, Cucchiaro J, Xu J, Sarma K, Pikalov A, Kane JM
  Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study. Schizophr Res. 2013 Jun;147(1):95-102. doi: 10.1016/j.schres.2

A Phase 3 Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Lurasidone in Subjects With Schizophrenia (PEARL 3 Extension Study)

Details for clinical trial NCT00789698